aTyr Pharma, Inc.ATYRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank85
3Y CAGR+48.9%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+48.9%/yr
Annual compound
Percentile
P85
Within normal range
vs 3Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$3.50M-10.0%
2024$3.89M-13.9%
2023$4.52M+326.2%
2022$1.06M+345.8%
2021$238000.00+174.6%
2020$-319000.00+59.4%
2019$-785000.00+53.7%
2018$-1.70M-59.6%
2017$-1.06M-174.0%
2016$1.44M-